Medibank: Still too expensive

Leyland Private Asset Management

Trusted and Confidential Asset Management Advisors

Medibank Private Limited is Australia’s largest health insurer with 3.8 million members giving it 29% of the market. The company operates under: 1) Medibank, the premier product & 2) AHM, a budget-friendly option. Last year, the government outlined several risks to the sector, including an ageing population, growth in chronic diseases, increasing patient expectations about access to services and the number and range of health services provided. Despite the negatives, 13.3m Australian's have general treatment cover (55.8% of the population) with the government spending $5.8b on rebates last year. MPL seems good value vs. its key competitor, NIB. MPL currently trades on 16x earnings paying a 4.6% dividend, whilst NIB trades on 21x earnings and pays a 3.3% dividend. Due to brand deterioration and the disillusionment of many customers, we still believe that the current price of Medibank is too expensive. Subscribe here: (VIEW LINK)


Leyland Private Asset Management
Trusted and Confidential Asset Management Advisors

Founded in 2003, Leyland Private Asset Management is an independently owned firm specialising in Australian Stock Market and Fixed Interest Investments for individuals, companies, self-managed super funds, institutions and family offices.

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.